IGF2BP3 and neoplasm: Among these proteins, knockdown of the IGF2BP3 gene inhibits hypoxia-induced angiogenesis in vivo by downregulating HIF1A, which inhibits angiogenesis mainly by reducing the expression of pro-angiogenic factor (VEGF) in tumor tissues [39, 69].